Clearmind Medicine (CMND) Other Non Operating Income (2022 - 2026)
Clearmind Medicine (CMND) posted quarterly Other Non Operating Income of -$4233.0 for Q2 2026, up 46.2% year-over-year from -$2895.4 in Q2 2025, and down 167.6% quarter-over-quarter from $6262.0 in Q1 2026.
Clearmind Medicine (CMND) Other Non Operating Income (2022 - 2026) Analysis & Trends
Clearmind Medicine's Other Non Operating Income history runs 5 years deep, the most recent figure standing at -$4233.0 for Q2 2026.
- In Q2 2026, Other Non Operating Income rose 46.2% year-over-year to -$4233.0; the TTM figure through Apr 2026 stood at $7611.0 (up 146.29% YoY), while the FY2025 annual figure was $3378.0, up 156.04% from the prior year.
- Other Non Operating Income for Q2 2026 stood at -$4233.0, down from $6262.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $60797.0 in Q3 2022, with the low at -$61144.0 in Q4 2022.
- The 5-year median for Other Non Operating Income is -$4450.0 (2025), against an average of -$7470.4.
- The sharpest annual moves came in 2025 and 2026: Other Non Operating Income plunged 726.93% in 2025, then surged 240.72% in 2026.
- Clearmind Medicine's Other Non Operating Income stood at -$61144.0 in 2022, then rose by 0.31% to -$60952.0 in 2023, then surged by 91.17% to -$5380.0 in 2024, then jumped by 146.73% to $2514.0 in 2025, then sank by 268.38% to -$4233.0 in 2026.
- Business Quant data shows CMND's Other Non Operating Income at -$4233.0 in Q2 2026, $6262.0 in Q1 2026, and $2514.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Clearmind Medicine | 537,435.54 | -13.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -4,233.00 |
| Jan 31, 2026 | 6,262.00 |
| Oct 31, 2025 | 2,514.00 |
| Jul 31, 2025 | 3,068.00 |
| Apr 30, 2025 | -7,868.00 |
| Jan 31, 2025 | -4,450.00 |
| Jul 31, 2024 | -5,380.00 |
| Apr 30, 2024 | 1,255.00 |
| Jan 31, 2024 | 1,416.00 |
| Oct 31, 2023 | -60,952.00 |
| Jul 31, 2023 | 33,645.00 |
| Apr 30, 2023 | -45,046.53 |
| Jan 31, 2023 | -34,404.00 |
| Oct 31, 2022 | -61,144.00 |
| Jul 31, 2022 | 60,797.00 |
| Apr 30, 2022 | -7,369.71 |
| Jan 31, 2022 | -5,107.09 |